|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| C07K 14/51 | |||
| G01N 33/53 | |||
| A61P 19/10 |
| (11) | Patento numeris | 1636270 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04776553.2 |
| Europos patento paraiškos padavimo data | 2004-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-03-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/018912 |
| Data | 2004-06-15 |
| (87) | Numeris | WO 2005/014650 |
| Data | 2005-02-17 |
| (30) | Numeris | Data | Šalis |
| 478977 P | 2003-06-16 | US |
| (72) |
WINKLER, David, G., US
SHI, Jiye, US
LATHAM, John, US
|
| (73) |
UCB Pharma S.A.,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |
| ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |